TUMOR INTERACTION WITH HEMOSTASIS - THE RATIONALE FOR THE USE OF PLATELET INHIBITORS AND ANTICOAGULANTS IN THE TREATMENT OF CANCER

被引：40
|
作者：
ALMONDHIRY, H
机构：
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 1984年 / 16卷 / 02期
关键词：
D O I：
10.1002/ajh.2830160213
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：193 / 202
页数：10
相关论文
共 50 条
  • [1] RATIONALE OF ANTICOAGULANTS IN TREATMENT OF CANCER
    CLIFFTON, EE
    GROSSI, CE
    JOURNAL OF MEDICINE, 1974, 5 (1-3) : 107 - 113
  • [2] Treatment of cancer with anticoagulants: Rationale in the treatment of melanoma
    Ornstein, DL
    Zacharski, LR
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) : 157 - 161
  • [3] Treatment of Cancer with Anticoagulants: Rationale in the Treatment of Melanoma
    Deborah L. Ornstein
    Leo R. Zacharski
    International Journal of Hematology, 2001, 73 : 157 - 161
  • [4] The Perioperative Management of Treatment With Anticoagulants and Platelet Aggregation Inhibitors
    Schlitt, Axel
    Jambor, Csilla
    Spannagl, Michael
    Gogarten, Wiebke
    Schilling, Tom
    Zwissler, Bernhard
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (31-32): : 525 - U42
  • [5] Treatment of unstable angina: The role of platelet inhibitors and anticoagulants
    Cohen, M
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 (03): : 147 - 159
  • [6] Rationale for the use of platelet aggregation inhibitors in PAD patients
    Agnelli, G
    VASCULAR MEDICINE, 2001, 6 (03) : 13 - 15
  • [7] Efficacy of anticoagulants and platelet inhibitors in cancer-induced thrombosis
    Cloonan, Melissa E.
    DiNapoli, Marianne
    Mousa, Shaker A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (04) : 341 - 345
  • [8] Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer
    Pruthi, RS
    Derksen, E
    Gaston, K
    Wallen, EM
    UROLOGY, 2004, 64 (04) : 637 - 642
  • [9] Aromatase inhibitors: Rationale and use in breast cancer
    Osborne, C
    Tripathy, D
    ANNUAL REVIEW OF MEDICINE, 2005, 56 : 103 - +
  • [10] PREVENTION AND TREATMENT OF THROMBOEMBOLISM - USE OF PLATELET ANTIADHESIVES, ANTICOAGULANTS AND FIBRINOLYTICS
    ESCUDERODELAPENA, J
    ARCHIVOS DEL INSTITUTO DE CARDIOLOGIA DE MEXICO, 1975, 45 (05): : 678 - 682
12345